Dr. Claudia Schulz

Dr. rer. nat., B.Sc., M.Sc. (Molecular Medicine)
Patent Attorney, European Patent Attorney, European Trademark & Design Attorney



  • molecular medicine
  • medical technology
  • biology
  • biochemistry
  • biotechnology
  • pharmacy
  • chemistry

patent issue proceedings
participating in patent litigations

Dr. Claudia Schulz has been working for Prüfer & Partner since 2013. She became European Patent Attorney in 2017, and German Patent Attorney in 2018.
Before she was working at Prüfer & Partner, she was a postdoc at the Institute for Experimental Tumour Research in Paediatrics at the Goethe University in Frankfurt am Main and joined the Cancer Institute of New Jersey, USA for research studies.
Dr. Claudia Schulz studied Molecular Medicine at the University of Ulm and did her PhD as a scholar of the International Graduate School in Molecular Medicine within the framework of the excellence initiative of the federal and state governments.
While studying, she interned at Labor Dr. Merk & Kollegen in Ochsenhausen, thereby gaining practical experience in the industry. At that time, she worked as a research associate at the Institute for Molecular Virology.

Tchoghandjian A, Jennewein C et al., Cell Death Differ., 2014 May;21(5):735-47
Westhoff MA et al., PLoS One. 2013 Dec 31;8(12):e83128
Westhoff MA et al., Mol Cancer Res. 2013 Dec;11(12):1611-23
Tchoghandjian A, Jennewein C et al., Cell Death Dis. 2013 Mar 28;4:e564
Laukens B, Jennewein C (equally contributing authors) et al., Neoplasia. 2011 Oct;13(10):971-9
Berger R, Jennewein C et al., Mol Cancer Ther. 2011 Oct;10(10):1867-75
Jennewein C et al., Oncogene. 2012 Mar 15;31(11):1468-74

German, English, French (basic knowledge) 


« back